Utility of fractional exhaled nitric oxide suppression as a prediction tool for progression to biologic therapy. (2021)

First Author: Butler CA
Attributed to:  United Kingdom Refractory Asthma Stratification Programme (RASP-UK) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1183/23120541.00273-2021

PubMed Identifier: 34549044

Publication URI: http://europepmc.org/abstract/MED/34549044

Type: Journal Article/Review

Volume: 7

Parent Publication: ERJ open research

Issue: 3

ISSN: 2312-0541